Vimarsana
Biggest News Aggregation in the World

Page 3 - Acceleron Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acceleron Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acceleron Pharma Today - Breaking & Trending Today

FDA approves Merck lung disease drug acquired in $11B deal - Vimarsana News

FDA approves Merck lung disease drug acquired in $11B deal

BioPharma

US FDA Approves Merck's Therapy for Rare Lung Condition - Vimarsana News

US FDA Approves Merck's Therapy for Rare Lung Condition

The U.S. Food and Drug Administration on Tuesday approved Merck's treatment for adults with high blood pressure due to constriction of lung arteries, adding another...

Merck's Winrevair earns FDA approval in milestone moment for PAH treatment - Vimarsana News

Merck's Winrevair earns FDA approval in milestone moment for PAH treatment

The FDA approval marks a milestone for Merck, which acquired the pulmonary arterial hypertension treatment in 2021 through its $11.5 billion buyout of Acceleron Pharma.

FDA approves Merck drug sotatercept for rare, deadly lung condition - Vimarsana News

FDA approves Merck drug sotatercept for rare, deadly lung condition

The approval is a win for Merck, which is working to diversify its revenue stream as its blockbuster cancer drug Keytruda nears a loss of market exclusivity.

Source: cnbc.com
FDA approves Merck's drug for rare, deadly lung condition - Vimarsana News

FDA approves Merck's drug for rare, deadly lung condition

The Food and Drug Administration on Tuesday approved a drug from Merck designed to treat a progressive and life-threatening lung condition in a win for both the...